Contraceptive implants and efavirenz-based ART: friend or foe?

Lancet HIV. 2015 Nov;2(11):e454-5. doi: 10.1016/S2352-3018(15)00204-0. Epub 2015 Oct 22.

Authors

Chelsea Morroni¹, Linda-Gail Bekker², Helen Rees³

Affiliations

¹ EGA Institute for Women's Health and Institute for Global Health, University College London, London, UK; Botswana-U Penn Partnership, PO Box AC157 ACH, Gaborone, Botswana. Electronic address: [email protected].
² Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
³ Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa.

PMID: 26520921
DOI: 10.1016/S2352-3018(15)00204-0

No abstract available

Publication types

Comment

MeSH terms

Anti-HIV Agents / therapeutic use*
Contraceptive Agents / therapeutic use*
Contraceptive Agents, Female / therapeutic use
Drug Implants / therapeutic use
HIV Infections / drug therapy
Humans

Substances

Anti-HIV Agents
Contraceptive Agents
Contraceptive Agents, Female
Drug Implants

Grants and funding

P30 AI045008/AI/NIAID NIH HHS/United States